Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators

Information

  • Research Project
  • 10298222
  • ApplicationId
    10298222
  • Core Project Number
    R01CA253330
  • Full Project Number
    1R01CA253330-01A1
  • Serial Number
    253330
  • FOA Number
    PAR-18-869
  • Sub Project Id
  • Project Start Date
    9/10/2021 - 2 years ago
  • Project End Date
    8/31/2024 - 2 months from now
  • Program Officer Name
    ST GERMAIN, DIANE
  • Budget Start Date
    9/10/2021 - 2 years ago
  • Budget End Date
    8/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    9/10/2021 - 2 years ago
Organizations

Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators

PROJECT SUMMARY Nearly 600,000 older Americans die a cancer-related death each year. Maintaining human dignity is central to quality of life for patients with serious illness. Our long-term goal is to foster optimal humanistic modes of patient-centered clinical communication. We focus in the proposed study on Dignity Therapy (DT) which was designed to preserve cancer patients? dignity despite declines in their health. Theoretically grounded in gerontological life review research, DT involves a therapist guiding a patient to generate their own unique, structured life narrative. Patients report benefits of DT but to date the mechanisms of DT have not been empirically investigated. As the use of this therapy spreads internationally, there is thus a pressing need to delineate precise mechanisms. The proposed study is the first to reliably analyze the content of older cancer patients? interactions with the therapist in DT sessions (N=280 older adults who received DT). Our design allows for investigation of two mechanisms theoretically central to improving patient dignity through DT. These proposed mechanisms, empathic provider-patient communication during DT and richness of the patient?s life narrative produced during DT, will be used analytically as predictors of pre-to-post-therapy change in dignity impact. Our proposed study uses innovative methodological tools: it will employ both interactional and narrative analysis, grounded in the patient?s own experience, to establish mechanisms through which the therapy affects patient dignity. Past research has suffered due to assessment of conceptually distal outcomes of receiving DT. In response, the proposed outcomes have been chosen as proximal constructs closely guided by DT?s conceptual underpinnings. Our primary outcome of interest is the extent to which the patients sense of dignity increases from pre-to-posttest (i.e., Dignity Impact). Another aspect of the proposed study is to investigate when patients are most able to engage in DT. This will be accomplished through assessing whether extent of dignity impact after DT is moderated by patients? symptom severity. Together, delineating mechanisms and identifying best timing for patient engagement in DT will provide substantial progress in implementing DT as a form of psychosocial care for older cancer patients. Our interdisciplinary team ensures that study findings will be implemented to improve DT training and delivery. This includes our innovative dissemination plan of hosting a Science of Care Summit with national opinion leaders. Our specific aims are as follows: SA1: Delineate the relation between empathic communication and higher patient dignity impact (primary outcome) pre-to-post- therapy. SA2: Investigate the relation between richness of the life narrative the patient is guided to produce during DT, and dignity impact (primary outcome) pre-to-post therapy.SA3: Identify the best-fitting model of relation of patient-provider empathic communication to post-therapy impact on patients? dignity, with narrative richness as a mediator and patients? symptom severity as a moderator (i.e., moderated-mediation analyses).

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R01
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
    228750
  • Indirect Cost Amount
    113207
  • Total Cost
    341957
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    395
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NCI:341957\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    CMGC
  • Study Section Name
    Clinical Management in General Care Settings Study Section
  • Organization Name
    UNIVERSITY OF FLORIDA
  • Organization Department
    MISCELLANEOUS
  • Organization DUNS
    969663814
  • Organization City
    GAINESVILLE
  • Organization State
    FL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    326115500
  • Organization District
    UNITED STATES